New pill takes aim at Hard-to-Treat cancers
NCT ID NCT06425926
First seen Mar 31, 2026 · Last updated May 12, 2026 · Updated 5 times
Summary
This early-stage study tests an experimental oral drug called GIM-531 in people with advanced solid tumors (including stage IV melanoma) that have stopped responding to standard treatments. The drug works by targeting certain immune cells to help the body fight cancer. Researchers will check safety, side effects, and how well the drug works alone or with another immunotherapy. About 117 participants will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Comprehensive Blood and Cancer Center
RECRUITINGBakersfield, California, 93309, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
HonorHealth Research Institute
RECRUITINGScottsdale, Arizona, 85258, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana
RECRUITINGBillings, Montana, 59102, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Providence Medical Foundation
RECRUITINGFullerton, California, 92835, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Tennessee Oncology, PLLC
RECRUITINGNashville, Tennessee, 37203, United States
Contact
-
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate
RECRUITINGLos Angeles, California, 90025, United States
Contact Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UCSF Helen Diller Family Comprehensive Cancer Center
RECRUITINGSan Francisco, California, 94143, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Cincinnati Cancer Center
RECRUITINGCincinnati, Ohio, 45267, United States
Contact
-
Virginia Commonwealth University
RECRUITINGRichmond, Virginia, 23219, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Weill Cornell Medicine - New York Presbyterian Hospital
RECRUITINGNew York, New York, 10065, United States
Contact
Conditions
Explore the condition pages connected to this study.